Effects of time-restricted feeding on body weight and metabolism. A systematic review and meta-analysis
Restriction in meal timing has emerged as a promising dietary approach for the management of obesity and dysmetabolic diseases. The present systematic review and meta-analysis summarized the most recent evidence on the effect of time-restricted feeding (TRF) on weight-loss and cardiometabolic variab...
Gespeichert in:
Veröffentlicht in: | Reviews in endocrine & metabolic disorders 2020-03, Vol.21 (1), p.17-33 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Restriction in meal timing has emerged as a promising dietary approach for the management of obesity and dysmetabolic diseases. The present systematic review and meta-analysis summarized the most recent evidence on the effect of time-restricted feeding (TRF) on weight-loss and cardiometabolic variables in comparison with unrestricted-time regimens. Studies involving TRF regimen were systematically searched up to January 2019. Effect size was expressed as weighted mean difference (WMD) and 95% confidence intervals (CI). A total of 11 studies, 5 randomized controlled trials and 6 observational, were included. All selected studies had a control group without time restriction; hours of fasting ranged from 12-h until 20-h and study duration from 4 to 8-weeks. Most studies involved the Ramadan fasting. TRF determined a greater weight-loss than control regimens (11 studies,
n
= 485 subjects) (WMD: −1.07 kg, 95%CI: −1.74 to −0.40;
p
= 0.002; I
2
= 56.2%), unrelated to study design. The subgroup analysis showed an inverse association between TRF and fat free mass in observational studies (WMD: −1.33 kg, 95%CI: −2.55 to −0.11;
p
= 0.03; I
2
= 0%). An overall significant reduction in fasting glucose concentrations was observed with TRF regimens (7 studies,
n =
363 subjects) (WMD: −1.71 mg/dL, 95%CI: −3.20 to −0.21;
p
= 0.03; I
2
= 0%), above all in trials (WMD:-2.45 mg/dL, 95%CI: −4.72 to −0.17; p = 0.03; I
2
= 0%). No between-group differences in the other variables were found. TRF regimens achieved a superior effect in promoting weight-loss and reducing fasting glucose compared to approaches with unrestricted time in meal consumption. However, long-term and well-designed trials are needed to draw definitive conclusions. |
---|---|
ISSN: | 1389-9155 1573-2606 |
DOI: | 10.1007/s11154-019-09524-w |